78 related articles for article (PubMed ID: 24066863)
1. Improved lentiviral transduction of ALS motoneurons in vivo via dual targeting.
O'Leary VB; Ovsepian SV; Bodeker M; Dolly JO
Mol Pharm; 2013 Nov; 10(11):4195-206. PubMed ID: 24066863
[TBL] [Abstract][Full Text] [Related]
2. Internalization and retrograde axonal trafficking of tetanus toxin in motor neurons and trans-synaptic propagation at central synapses exceed those of its C-terminal-binding fragments.
Ovsepian SV; Bodeker M; O'Leary VB; Lawrence GW; Oliver Dolly J
Brain Struct Funct; 2015; 220(3):1825-38. PubMed ID: 25665801
[TBL] [Abstract][Full Text] [Related]
3. Innocuous full-length botulinum neurotoxin targets and promotes the expression of lentiviral vectors in central and autonomic neurons.
O'Leary VB; Ovsepian SV; Raghunath A; Huo Q; Lawrence GW; Smith L; Dolly JO
Gene Ther; 2011 Jul; 18(7):656-65. PubMed ID: 21368902
[TBL] [Abstract][Full Text] [Related]
4. Early signs of motoneuron vulnerability in a disease model system: Characterization of transverse slice cultures of spinal cord isolated from embryonic ALS mice.
Avossa D; Grandolfo M; Mazzarol F; Zatta M; Ballerini L
Neuroscience; 2006; 138(4):1179-94. PubMed ID: 16442737
[TBL] [Abstract][Full Text] [Related]
5. Local GDNF expression mediated by lentiviral vector protects facial nerve motoneurons but not spinal motoneurons in SOD1(G93A) transgenic mice.
Guillot S; Azzouz M; Déglon N; Zurn A; Aebischer P
Neurobiol Dis; 2004 Jun; 16(1):139-49. PubMed ID: 15207271
[TBL] [Abstract][Full Text] [Related]
6. IGF-1:tetanus toxin fragment C fusion protein improves delivery of IGF-1 to spinal cord but fails to prolong survival of ALS mice.
Chian RJ; Li J; Ay I; Celia SA; Kashi BB; Tamrazian E; Matthews JC; Bronson RT; Rossomando A; Pepinsky RB; Fishman PS; Brown RH; Francis JW
Brain Res; 2009 Sep; 1287():1-19. PubMed ID: 19563785
[TBL] [Abstract][Full Text] [Related]
7. Cervical spinal cord delivery of a rabies G protein pseudotyped lentiviral vector in the SOD-1 transgenic mouse. Invited submission from the Joint Section Meeting on Disorders of the Spine and Peripheral Nerves, March 2004.
Tanase K; Teng Q; Krishnaney AA; Liu JK; Garrity-Moses ME; Boulis NM
J Neurosurg Spine; 2004 Jul; 1(1):128-36. PubMed ID: 15291033
[TBL] [Abstract][Full Text] [Related]
8. Chimeric rabies SADB19-VSVg-pseudotyped lentiviral vectors mediate long-range retrograde transduction from the mouse spinal cord.
Schoderboeck L; Riad S; Bokor AM; Wicky HE; Strauss M; Bostina M; Oswald MJ; Empson RM; Hughes SM
Gene Ther; 2015 May; 22(5):357-64. PubMed ID: 25630949
[TBL] [Abstract][Full Text] [Related]
9. Increased motoneuron survival and improved neuromuscular function in transgenic ALS mice after intraspinal injection of an adeno-associated virus encoding Bcl-2.
Azzouz M; Hottinger A; Paterna JC; Zurn AD; Aebischer P; Büeler H
Hum Mol Genet; 2000 Mar; 9(5):803-11. PubMed ID: 10749988
[TBL] [Abstract][Full Text] [Related]
10. Olesoxime delays muscle denervation, astrogliosis, microglial activation and motoneuron death in an ALS mouse model.
Sunyach C; Michaud M; Arnoux T; Bernard-Marissal N; Aebischer J; Latyszenok V; Gouarné C; Raoul C; Pruss RM; Bordet T; Pettmann B
Neuropharmacology; 2012 Jun; 62(7):2346-52. PubMed ID: 22369784
[TBL] [Abstract][Full Text] [Related]
11. (Strept)avidin-displaying lentiviruses as versatile tools for targeting and dual imaging of gene delivery.
Kaikkonen MU; Lesch HP; Pikkarainen J; Räty JK; Vuorio T; Huhtala T; Taavitsainen M; Laitinen T; Tuunanen P; Gröhn O; Närvänen A; Airenne KJ; Ylä-Herttuala S
Gene Ther; 2009 Jul; 16(7):894-904. PubMed ID: 19440224
[TBL] [Abstract][Full Text] [Related]
12. Regulation of system x(c)- in the SOD1-G93A mouse model of ALS.
Albano R; Liu X; Lobner D
Exp Neurol; 2013 Dec; 250():69-73. PubMed ID: 24041987
[TBL] [Abstract][Full Text] [Related]
13. Treatment with trichostatin A initiated after disease onset delays disease progression and increases survival in a mouse model of amyotrophic lateral sclerosis.
Yoo YE; Ko CP
Exp Neurol; 2011 Sep; 231(1):147-59. PubMed ID: 21712032
[TBL] [Abstract][Full Text] [Related]
14. Lentivirus-mediated estrogen receptor α overexpression in the central nervous system ameliorates experimental autoimmune encephalomyelitis in mice.
Hu X; Qin X
Int J Mol Med; 2013 May; 31(5):1209-21. PubMed ID: 23525227
[TBL] [Abstract][Full Text] [Related]
15. A glial cell line-derived neurotrophic factor (GDNF):tetanus toxin fragment C protein conjugate improves delivery of GDNF to spinal cord motor neurons in mice.
Larsen KE; Benn SC; Ay I; Chian RJ; Celia SA; Remington MP; Bejarano M; Liu M; Ross J; Carmillo P; Sah D; Phillips KA; Sulzer D; Pepinsky RB; Fishman PS; Brown RH; Francis JW
Brain Res; 2006 Nov; 1120(1):1-12. PubMed ID: 17020749
[TBL] [Abstract][Full Text] [Related]
16. Expression of heat shock transcription factor 1 and its downstream target protein T-cell death associated gene 51 in the spinal cord of a mouse model of amyotrophic lateral sclerosis.
Mimoto T; Morimoto N; Miyazaki K; Kurata T; Sato K; Ikeda Y; Abe K
Brain Res; 2012 Dec; 1488():123-31. PubMed ID: 23063459
[TBL] [Abstract][Full Text] [Related]
17. Lack of a synergistic effect of a non-viral ALS gene therapy based on BDNF and a TTC fusion molecule.
Calvo AC; Moreno-Igoa M; Mancuso R; Manzano R; Oliván S; Muñoz MJ; Penas C; Zaragoza P; Navarro X; Osta R
Orphanet J Rare Dis; 2011 Mar; 6():10. PubMed ID: 21418619
[TBL] [Abstract][Full Text] [Related]
18. Neuronal targeting of cardiotrophin-1 by coupling with tetanus toxin C fragment.
Bordet T; Castelnau-Ptakhine L; Fauchereau F; Friocourt G; Kahn A; Haase G
Mol Cell Neurosci; 2001 May; 17(5):842-54. PubMed ID: 11358482
[TBL] [Abstract][Full Text] [Related]
19. A genetic fusion GDNF-C fragment of tetanus toxin prolongs survival in a symptomatic mouse ALS model.
Ciriza J; Moreno-Igoa M; Calvo AC; Yague G; Palacio J; Miana-Mena FJ; Muñoz MJ; Zaragoza P; Brûlet P; Osta R
Restor Neurol Neurosci; 2008; 26(6):459-65. PubMed ID: 19096133
[TBL] [Abstract][Full Text] [Related]
20. Gene expression changes in spinal motoneurons of the SOD1(G93A) transgenic model for ALS after treatment with G-CSF.
Henriques A; Kastner S; Chatzikonstantinou E; Pitzer C; Plaas C; Kirsch F; Wafzig O; Krüger C; Spoelgen R; Gonzalez De Aguilar JL; Gretz N; Schneider A
Front Cell Neurosci; 2014; 8():464. PubMed ID: 25653590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
